|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 403/12 | (2006.01) |
| A61P 9/00 | (2006.01) | ||
| A61K 31/506 | (2006.01) |
| (11) | Number of the document | 1833821 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05802290.6 |
| Date of filing the European patent application | 2005-11-11 | |
| (97) | Date of publication of the European application | 2007-09-19 |
| (45) | Date of publication and mention of the grant of the patent | 2011-03-30 |
| (46) | Date of publication of the claims translation | 2011-08-25 |
| (86) | Number | PCT/IB2005/053716 |
| Date | 2005-11-11 |
| (87) | Number | WO 2006/051502 |
| Date | 2006-05-18 |
| (30) | Number | Date | Country code |
| PCT/EP2004/0127 | 2004-11-11 | WO |
| (72) |
BOSS, Christoph, CH
FISCHLI, Walter, CH
WELLER, Thomas, CH
CLOZEL, Martine, CH
BOLLI, Martin, CH
|
| (73) |
Actelion Pharmaceuticals Ltd.,
Gewerbestrasse 16, 4123 Allschwil,
CH
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Sulfamidai, kaip endotelino receptoriaus antagonistai širdies kraujagyslių ligų gydymui |
| SULFAMIDES AS ENDOTHELIN RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES |
| Payment date | Validity (years) | Amount | |
| 2013-10-25 | 9 | 720.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2014-11-11 |